Frances Murray, MD
Family Medicine · Bridgeport, WVNPI 1043262942
Payments from drug & device makers
Across 704 payments — averaging $14.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$1K
- Amgen$1K
- Astellas Pharma US Inc$816
- AstraZeneca$787
- Lilly USA, LLC$496
- plus $4K from 27 others
What the payments were for
- Food & beverage$10,24699%
- Education$941%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 137 | $1,814 |
| Novo Nordisk | 82 | $1,423 |
| Amgen | 86 | $1,116 |
| Astellas Pharma US Inc | 53 | $816 |
| AstraZeneca | 33 | $787 |
| Lilly USA, LLC | 37 | $496 |
| Pfizer | 45 | $445 |
| Exact Sciences | 23 | $338 |
| Boehringer Ingelheim | 24 | $327 |
| Shield Therapeutics Inc | 8 | $301 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $287 |
| Novartis | 19 | $264 |
| Sanofi-aventis U.S. LLC | 20 | $210 |
| GSK | 14 | $210 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $198 |
| Johnson & Johnson | 13 | $175 |
| Esperion Therapeutics, Inc. | 9 | $158 |
| Bayer | 9 | $150 |
| Merck | 17 | $150 |
| Amarin Pharma, Inc. | 10 | $148 |
| Phathom Pharmaceuticals, Inc. | 6 | $98 |
| Abbott | 4 | $75 |
| Verona Pharma, Inc. | 4 | $74 |
| Dexcom, Inc. | 3 | $40 |
| Daiichi Sankyo Inc. | 3 | $40 |
| Ironwood Pharmaceuticals, Inc | 2 | $35 |
| Avanir Pharmaceuticals, Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Eisai Inc. | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $26 |
| Viatris Specialty LLC | 1 | $15 |
| Mylan Specialty L.p. | 1 | $14 |
| Insulet Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,340 in reported general payments places this provider in the 95th percentile of 843 family medicine providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 38 | $61,956 |
| TrulicityDulaglutide | 26 | $60,039 |
| JanuviaSitagliptin Phosphate | 26 | $39,537 |
| JardianceEmpagliflozin | 24 | $37,237 |
| XareltoRivaroxaban | 22 | $33,888 |
| OzempicSemaglutide | 12 | $30,410 |
| EliquisApixaban | 16 | $29,192 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $21,539 |
| FarxigaDapagliflozin Propanediol | 12 | $18,255 |
| SynthroidLevothyroxine Sodium | 156 | $17,853 |
| TradjentaLinagliptin | 13 | $16,561 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 37 | $9,803 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $9,501 |
| Rosuvastatin Calcium | 309 | $5,178 |
| Novolog FlexpenInsulin Aspart | 14 | $3,870 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $496 | $121,99464 claims |
| Boehringer IngelheimJardiance, Tradjenta | $327 | $53,79837 claims |
| MerckJanuvia | $150 | $39,53726 claims |
| Johnson & JohnsonXarelto | $175 | $33,88822 claims |
| Novo NordiskOzempic | $1,423 | $30,41012 claims |
| PfizerEliquis | $445 | $29,19216 claims |
| GSKTrelegy Ellipta | $210 | $21,53912 claims |
| AstraZenecaFarxiga | $787 | $18,25512 claims |
| AbbVieSynthroid | $1,814 | $17,853156 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 843 family medicine providers in West Virginia.
Other family medicine in Bridgeport
- David HessBridgeport$20K
- Stephen FryerBridgeport$9K
- Brittanie WestBridgeport$8K
- Wilbur SineMorgantown$179K
- Dorian WilliamsMorgantown$169K
- Julie DetempleSouth Charleston$129K
- Clemente DiazRichwood$127K
- John CornellHuntington$94K
- Mark CucuzzellaHarpers Ferry$59K
- Courtney PilkertonMorgantown$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.